TCON

TRACON Pharmaceuticals, Inc. Common Stock
TCON

Overview Fund Activity
Delisted

TCON was delisted on the 27th of June, 2024.

Back to rankings

23 hedge funds and large institutions have $41.9M invested in TRACON Pharmaceuticals, Inc. Common Stock in 2015 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 11 increasing their positions, 3 reducing their positions, and 6 closing their positions.

Holders
23
Holders Change
-4
Holders Change %
-14.81%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
11
Reduced
3
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
EAM
1
Eventide Asset Management
Massachusetts
$4.78M
2
CS
2
Candriam SCA
Luxembourg
$1.66M
3
WG
3
Welch Group
Alabama
$553K
4
CAM
4
ClariVest Asset Management
California
$267K
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$1.37M

Top Sellers

1
JGC
1
J. Goldman & Co
New York
$0
2
Bank of America
2
Bank of America
North Carolina
$0
3
WSA
3
Wall Street Associates
California
$2.23M
4
Janus Henderson Group
4
Janus Henderson Group
United Kingdom
$0
5
TC
5
TFS Capital
Pennsylvania
$96K
Name Holding Trade Value Shares
Change 		Shares
Change %
Janus Henderson Group
26
Janus Henderson Group
United Kingdom
– -$63K -32 Closed
TRCT
27
Tower Research Capital (TRC)
New York
– -$13K -7 Closed
PCM
28
Prelude Capital Management
New York
– -$2K -1 Closed
Morgan Stanley
29
Morgan Stanley
New York
– -$3K -1 Closed
1
2